Risk Factors for Periprosthetic Fractures Following Total Hip Arthroplasty in Patients Younger Than 50 Years

Eric Cui1, Jackson W Durbin1, Amy Zhao2

  • 1Department of Orthopedic Surgery, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.

The Journal of Arthroplasty
|September 3, 2025
PubMed

Insights

Periprosthetic fractures (PPF) after total hip arthroplasty (THA) in patients under 50 are linked to conditions like osteonecrosis and neurologic disease. Hip osteoarthritis and being male are protective factors against PPF.

Area of Science:

  • Orthopedic Surgery
  • Biostatistics
  • Epidemiology

Background:

  • Total hip arthroplasty (THA) is increasingly performed in younger populations.
  • This trend is expected to increase the incidence of periprosthetic fractures (PPF) in this demographic.
  • Identifying risk factors for PPF in young patients is crucial for improving outcomes.

Purpose of the Study:

  • To identify specific risk factors for periprosthetic fractures (PPF) following total hip arthroplasty (THA) in patients under 50 years of age.
  • To determine factors that may be protective against PPF in this young patient cohort.

Main Methods:

  • A retrospective study analyzing 270,986 patients who underwent primary THA.
  • Patients were stratified into age cohorts, with the 51-60 years group serving as the reference.
  • Multivariate regression analysis was employed to identify risk and protective factors, with a significance level adjusted by Bonferroni correction (P < 0.03).

Main Results:

  • Key risk factors for PPF in patients under 50 included THA for osteonecrosis, history of arrhythmia, peripheral vascular disease, paralysis, neurologic disease, pulmonary disease, chronic kidney disease, anemia with blood loss, and alcohol abuse.
  • Protective factors identified were hip osteoarthritis, being male, and being in the 41-50 years age group.

Conclusions:

  • Several significant risk factors for PPF after THA in patients under 50 have been identified.
  • Hip osteoarthritis, male sex, and older age within this cohort (41-50 years) demonstrate a protective effect.
  • These findings can aid surgeons in identifying high-risk patients and optimizing care to prevent PPF.
Abstract